Daiichi Sankyo Company, Limited announced the appointment of new Group corporate officers, effective April 1, 2016. Yuki Sato appointed as Representative Director, Member of the Board; Takeshi Ogita appointed as Member of the Board; Sunao Manabe appointed as Member of the Board Executive Vice President, Head of General Affairs & Human Resources Div. and Head of Medical Affairs Div.; Katsumi Fujimoto appointed as Senior Executive Officer, Head of Supply Chain Div.; Toshiaki Tojo appointed as Senior Executive Officer in charge of Vaccine Business; Satoru Kimura appointed as Senior Executive Officer, Head of Sales & Marketing Div.; Ryoji Nagasaka appointed as Executive Officer, Vice President of Secretariat Dept.; Junichi Koga appointed as Executive Officer, Head of R&D Div.

and Vice President ofResearch Technology Function, and in charge of Biologics; Koichi Akahane appointed as Executive Officer, Vice President of Oncology Function, R&D Div.; Kohei Wada appointed as Corporate Officer Corporate Officer, Vice President of Development Function, R&D Div.; Kentaro Takamura appointed as Corporate Officer Vice President of Finance & Accounting Dept., Corporate Management Div.; Ryoichi Watanabe appointed as Corporate Officer Vice President of Internal Audit Dept.; Junichi Fukute appointed as Corporate Officer, Vice President of Supply Chain Planning Dept., Supply Chain Div.; Kenji Katsumi appointed as Corporate Officer, Vice President of Supply Chain Planning Dept., Supply Chain Div.; Kentaro Murakawa appointed as Corporate Officer, Vice President of Tokyo Branch, Sales & Marketing Div.; and Hirosumi Izawa appointed as Corporate Officer, Head of Quality & Safety Management Div.